These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23568589)

  • 1. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.
    Beatty AL; Ku IA; Christenson RH; DeFilippi CR; Schiller NB; Whooley MA
    JAMA Intern Med; 2013 May; 173(9):763-9. PubMed ID: 23568589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
    Myhre PL; Claggett B; Ballantyne CM; Selvin E; Røsjø H; Omland T; Solomon SD; Skali H; Shah AM
    JAMA Cardiol; 2019 Oct; 4(10):997-1006. PubMed ID: 31483438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.
    Hsieh BP; Rogers AM; Na B; Wu AH; Schiller NB; Whooley MA
    Am Heart J; 2009 Oct; 158(4):673-9. PubMed ID: 19781430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.
    Koenig W; Breitling LP; Hahmann H; Wüsten B; Brenner H; Rothenbacher D
    Clin Chem; 2012 Aug; 58(8):1215-24. PubMed ID: 22634379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
    Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
    Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
    [No Abstract]   [Full Text] [Related]  

  • 6. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
    Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
    JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease.
    Biener M; Giannitsis E; Lamerz J; Mueller-Hennessen M; Vafaie M; Katus HA
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):409-418. PubMed ID: 26450785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Longitudinal Change in High-Sensitivity Troponin with All-Cause Mortality in Coronary Artery Disease: The Heart and Soul Study.
    Desai YB; Mishra RK; Fang Q; Whooley MA; Schiller NB
    Cardiology; 2020; 145(2):63-70. PubMed ID: 31910405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
    McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study.
    Beatty AL; Schiller NB; Whooley MA
    Arch Intern Med; 2012 Jul; 172(14):1096-102. PubMed ID: 22710902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
    Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
    Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
    Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
    Chen JR; Wang Q; Wu W; Zhang SJ
    Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease.
    Abiko M; Inai K; Shimada E; Asagai S; Nakanishi T
    J Cardiol; 2018 Apr; 71(4):389-393. PubMed ID: 29108668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study.
    Biener M; Giannitsis E; Hogrefe K; Mueller-Hennessen M; Fröhlich H; Katus HA; Frey N; Frankenstein L; Täger T
    Clin Res Cardiol; 2022 Mar; 111(3):333-342. PubMed ID: 34694435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.